Jared Andrew Shenson

Jared Andrew Shenson

Auto-generated profile, based on publicly available information

Jared Andrew Shenson

Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston Texas USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Applied Clinical Informatics
Verified
Journal Article
Open access
PDF file
SDS.E. Davis
S.E. Davis
JSJ.A. Shenson
J.A. Shenson
QCQ. Chen
Q. Chen
SRS.T. Rosenbloom
S.T. Rosenbloom
GJG.P. Jackson
G.P. Jackson
RCR.M. Cronin
R.M. Cronin
Summary: Objective: Patient portals are online applications that allow patients to interact with healthcare organizations. Portal adoption is increasing, and secure messaging between patients and health-care providers is an emerging form of outpatient interaction. Research about portals and messaging has focused on medical specialties. We characterized adoption of secure messaging and the contribution of messaging to outpatient interactions across diverse clinical specialties after broad portal deployment.Methods: This retrospective cohort study at Vanderbilt University Medical Center examined use of patient-initiated secure messages and clinic visits in the three years following full deployment of a patient portal across adult and pediatric specialties. We measured the proportion of outpatient interactions (i.e., messages plus clinic visits) conducted through secure messaging by specialty over time. Generalized estimating equations measured the likelihood of message-based versus clinic outpatient interaction across clinical specialties.Results: Over the study period, 2,422,114 clinic visits occurred, and 82,159 unique portal users initiated 948,428 messages to 1,924 recipients. Medicine participated in the most message exchanges (742,454 messages; 78.3% of all messages sent), followed by surgery (84,001; 8.9%) and obstetrics/gynecology (53,424; 5.6%). The proportion of outpatient interaction through messaging increased from 12.9% in 2008 to 33.0% in 2009 and 39.8% in 2010 (p<0.001). Medicine had the highest proportion of outpatient interaction conducted through messaging in 2008 (23.3% of out-patient interactions in medicine). By 2010, this proportion was highest for obstetrics/gynecology (83.4%), dermatology (71.6%), and medicine (56.7%). Growth in likelihood of message-based interaction was greater for anesthesiology, dermatology, obstetrics/gynecology, pediatrics, and psychiatry than for medicine (p<0.001).Conclusions: This study demonstrates rapid adoption of secure messaging across diverse clinical specialties, with messaging interactions exceeding face-to-face clinic visits for some specialties. As patient portal and secure messaging adoption increase beyond medicine and primary care, research is needed to understand the implications for provider workload and patient care.Citation: Cronin RM, Davis SE, Shenson JA, Chen Q, Rosenbloom ST, Jackson GP. Growth of secure messaging through a patient portal as a form of outpatient interaction across clinical specialties. Appl Clin Inf 2015; 6: 288–304http://dx.doi.org/10.4338/ACI-2014-12-RA-0117

16 April 2020 in Head & Neck
Verified
Journal Article
Open access
PDF file
MTMichael Topf
Michael Topf
JSJared A. Shenson
Jared A. Shenson
FHF. Christopher Holsinger
F. Christopher Holsinger
SWSamuel H. Wald
Samuel H. Wald
LCLisa J. Cianfichi
Lisa J. Cianfichi
JSJohn B. Sunwoo
John B. Sunwoo
The COVID‐19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non‐urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent—proceed with surgery, less urgent—consider postpone > 30 days, less urgent—consider postpone 30 to 90 days, and case‐by‐case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low‐risk and high‐risk surgery for transmission and role of preoperative COVID‐19 testing.

27 June 2015 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
JSJared A. Shenson
Jared A. Shenson
RCRobert M. Cronin
Robert M. Cronin
SDSharon E. Davis
Sharon E. Davis
QCQingxia Chen
Qingxia Chen
GJGretchen Purcell Jackson
Gretchen Purcell Jackson

3 October 2016 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
JSJared A. Shenson
Jared A. Shenson
JCJennifer N. Craig
Jennifer N. Craig
SRSarah L. Rohde
Sarah L. Rohde

1 May 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JGJustin W. Garyu
Justin W. Garyu
MUMohamed Uduman
Mohamed Uduman
ASAlex Stewart
Alex Stewart
JRJinxiu Rui
Jinxiu Rui
SDSongyan Deng
Songyan Deng
KHKevan C. Herold
Kevan C. Herold
Type 1 diabetes mellitus is caused by the killing of insulin-producing β cells by CD8+T cells. The disease progression, which is chronic, does not follow a course like responses to conventional antigens such as viruses, but accelerates as glucose tolerance deteriorates. To identify the unique features of the autoimmune effectors that may explain this behavior, we analyzed diabetogenic CD8+ T cells that recognize a peptide from the diabetes antigen IGRP (NRP-V7-reactive) in prediabetic NOD mice and compared them to others that shared their phenotype (CD44+CD62LloPD-1+CXCR3+) but negative for diabetes antigen tetramers and to LCMV (lymphocytic choriomeningitis)-reactive CD8+ T cells. There was an increase in the frequency of the NRP-V7-reactive cells coinciding with the time of glucose intolerance. The T cells persisted in hyperglycemic NOD mice maintained with an insulin pellet despite destruction of β cells. We compared gene expression in the three groups of cells compared with the other two subsets of cells, and the NRP-V7-reactive cells exhibited gene expression of memory precursor effector cells. They had reduced cellular proliferation and were less dependent on oxidative phosphorylation. When prediabetic NOD mice were treated with 2-deoxyglucose to block aerobic glycolysis, there was a reduction in the diabetes antigen versus other cells of similar phenotype and loss of lymphoid cells infiltrating the islets. In addition, treatment of NOD mice with 2-deoxyglucose resulted in improved β cell granularity. These findings identify a link between metabolic disturbances and autoreactive T cells that promotes development of autoimmune diabetes.

10 February 2017
Verified
Journal Article
Closed access
MMMary Masterman
Mary Masterman
RCRobert M Cronin
Robert M Cronin
SDSharon E Davis
Sharon E Davis
JSJared A Shenson
Jared A Shenson
GJGretchen P Jackson
Gretchen P Jackson